JPS5825671B2 - Method for producing 5-aroyl-pyrrole glyceryl acetate - Google Patents

Method for producing 5-aroyl-pyrrole glyceryl acetate

Info

Publication number
JPS5825671B2
JPS5825671B2 JP48009396A JP939673A JPS5825671B2 JP S5825671 B2 JPS5825671 B2 JP S5825671B2 JP 48009396 A JP48009396 A JP 48009396A JP 939673 A JP939673 A JP 939673A JP S5825671 B2 JPS5825671 B2 JP S5825671B2
Authority
JP
Japan
Prior art keywords
pyrrole
methyl
formula
aroyl
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48009396A
Other languages
Japanese (ja)
Other versions
JPS4880554A (en
Inventor
ロバート カーソン ジヨン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAC NEIL LAB
Original Assignee
MAC NEIL LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAC NEIL LAB filed Critical MAC NEIL LAB
Publication of JPS4880554A publication Critical patent/JPS4880554A/ja
Publication of JPS5825671B2 publication Critical patent/JPS5825671B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は抗炎症作用を示す5−アロイル−ピロール酢酸
エステルの製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing 5-aroyl-pyrrole acetate which exhibits anti-inflammatory activity.

上記エステルは低級アルキルエステル官能基ではな(グ
リセリルエステル官能基を有する点で先行技術(ベルギ
ー国特許第762060号明細書参照)のエステルとは
異なるエステルである。
The esters are different from the esters of the prior art (see Belgian Patent No. 762,060) in that they have a glyceryl ester function rather than a lower alkyl ester function.

本発明の方法により得られる新規グリセリルエステルは
構造的に次式(I)で示すことができる。
The novel glyceryl ester obtained by the method of the present invention can be structurally represented by the following formula (I).

(ただし、Arはフェニルまたは低級アルキル置換フェ
ニルを表わし、Rは低級アルキルを表わす0本明細書で
用いる”低級アルキル゛は直鎖であっても分枝鎖であっ
てもよ(,1〜約6個の炭素原子を有することができ、
例えばメチル、エチル、プロピル、イソプロピル、ブチ
ル、ペンチル、ヘキシルおよび同様なアルキルであるこ
とができる。
(However, Ar represents phenyl or lower alkyl-substituted phenyl, and R represents lower alkyl.) As used herein, "lower alkyl" may be linear or branched (, 1 to about can have 6 carbon atoms,
For example, it can be methyl, ethyl, propyl, isopropyl, butyl, pentyl, hexyl and similar alkyls.

式(I)の遊離酸形およびそのアルカリ金属塩はベルギ
ー国特許第762020等明細書に記載されている。
The free acid form of formula (I) and its alkali metal salts are described in Belgian Patent No. 762,020 and others.

本発明の主題グリセリルエステルの製造の出発原料とし
てここで用いる上記塩は対応する遊離酸から通常の手段
により、例えば遊離酸をアルカリ金属水酸化物(例えば
NaOH,KOHなど)のような適当な塩基で処理する
ことにより容易に得ることができる。
The salts used herein as starting materials for the preparation of the glyceryl esters that are the subject of the present invention are prepared by converting the corresponding free acid by conventional means, e.g. It can be easily obtained by processing with

上記アルカリ金属塩(II)を反応不活性を有機溶媒〔
例えばジメチルスルホキシド(DMSO))中でクロル
アセトニトリル(III)と反応させてそれぞれのピロ
ール酸のシアンメチルエステル(■)をつくり、これを
通常の方法で回収する。
React the above alkali metal salt (II) with an inert organic solvent [
For example, by reaction with chloroacetonitrile (III) in dimethyl sulfoxide (DMSO)), the respective cyan methyl ester (■) of pyrolic acid is produced, which is recovered by conventional methods.

例えば反応混合物を水と混ぜて生じた(■)の沈澱を集
める。
For example, the reaction mixture is mixed with water and the resulting precipitate (■) is collected.

また所望ならば適当な溶媒(例えばアセトニトリル)か
ら再結晶する。
If desired, it can also be recrystallized from a suitable solvent (eg acetonitrile).

本明細書中で使用する”反応不活性な有機溶媒”とは(
II)と(III)との反応を妨害せず且つ好ましくは
生成物(IV)を溶解する有機液体を意味する。
As used herein, "reaction-inert organic solvent" means (
It means an organic liquid which does not interfere with the reaction of II) and (III) and preferably dissolves the product (IV).

上記のようにして得たシアンメチルエステル(IV)を
次に塩基(例えば炭酸ナトリウムまたは炭酸カリウム)
の存在下で、好ましくは反応速度漬を大きくするため高
温度(約90℃)で、グリセリンのアセトンケタール(
V)で処理する。
The cyanogen methyl ester (IV) obtained as described above is then treated with a base (e.g. sodium carbonate or potassium carbonate).
The acetone ketal of glycerin (
V).

得られたそれぞれのピロール酸の2・2−ジメチル−1
・3−ジオキソラニルメチルエステル(Vl)を反応混
合物から通常の方法で回収する。
2,2-dimethyl-1 of each pyrolic acid obtained
- 3-dioxolanyl methyl ester (Vl) is recovered from the reaction mixture in the usual manner.

例えば、反応混合物を水と混合し、次いで適当な有機溶
媒(例えばエーテル)で抽出し、この有機抽出液相を水
または食塩水で洗い、有機抽出液相を乾燥し、溶媒を蒸
発し、且つ生成物(Vl)を適当な有機液体(例えばメ
タノール、エタノールなどのような低級アルカノール)
で処理して再結晶することによって回収する。
For example, the reaction mixture is mixed with water, then extracted with a suitable organic solvent (e.g. ether), the organic extract phase is washed with water or brine, the organic extract phase is dried, the solvent is evaporated, and The product (Vl) is mixed with a suitable organic liquid (e.g. lower alkanol such as methanol, ethanol etc.)
It is recovered by treatment with and recrystallization.

次にこの2・2−ジメチル−1・3−ジオキソラニルメ
チルエステル(Vl)を酢酸水溶液と共に加熱(90−
100℃に)することによって所望のグリセリルエステ
ル(■)に変える。
Next, this 2,2-dimethyl-1,3-dioxolanyl methyl ester (Vl) was heated (90-
100° C.) to the desired glyceryl ester (■).

反応が終了した時(約1〜2時間)、酢酸を蒸発除去し
、残留物を水とエステル(■)のための良好な有機溶媒
(例えばエーテル)とで分配し、有機相から通常の方法
で、例えば溶媒を蒸発し、得られた生成物を再結晶する
ことにより、エステル(■)を回収する。
When the reaction is complete (approximately 1-2 hours), the acetic acid is evaporated off, the residue is partitioned between water and a good organic solvent for the ester (e.g. ether), and the organic phase is evaporated in the usual manner. Then, the ester (■) is recovered, for example, by evaporating the solvent and recrystallizing the resulting product.

前述の反応は次の反応順序で示すことができる。The foregoing reactions can be illustrated in the following reaction sequence.

CX=式(■)のカルボキシル官能基に結合している残
基部分〕 式(I)のグリセリルエステルは約5〜約250 m9
7kg (体重)の範囲の投与量で標準カオリン−誘発
鼠足浮腫試験(ベルギー国特許第762060号明細書
記載)で示されるように抗炎症活性を持っている。
CX=residue moiety bonded to carboxyl functional group of formula (■)] Glyceryl ester of formula (I) is about 5 to about 250 m9
It has anti-inflammatory activity as shown in the standard kaolin-induced groin edema test (described in Belgian Patent No. 762,060) at doses in the range of 7 kg (body weight).

例えば、最も好ましい化合物である1−メチル−3−(
p−)ルオイル)−ピロール−2−酢酸グリセリルでは
、この試験で501n9/kg(体重)の投与量で26
%の抑制が観察される。
For example, the most preferred compound 1-methyl-3-(
For p-)luoyl)-pyrrole-2-glyceryl acetate, at a dose of 501n9/kg (body weight) in this study, 26
% inhibition is observed.

式(IV )のシアンメチルエステルおよび式(■)の
2・2−ジメチル−1・3−ジオキソラニルメチルエス
テルも新規化合物と考えられている。
Cyan methyl ester of formula (IV) and 2,2-dimethyl-1,3-dioxolanyl methyl ester of formula (■) are also considered new compounds.

これらの化合物は式(I)の化合物を製造するための前
駆物質として有用だという点で、本発明の付加的態様を
構成する。
These compounds constitute an additional aspect of the invention in that they are useful as precursors for preparing compounds of formula (I).

次に本発明の実施例を示すが、これらの実施例は本発明
を説明するためのものであり、本発明の範囲を限定する
ためのものではない。
Next, examples of the present invention will be shown, but these examples are for illustrating the present invention and are not intended to limit the scope of the present invention.

参考例 1 ■−メチルー5− (p−)ルオイル)−ピロール−2
−酢酸シアンメチル 22.3f(0,080モル)の1−メチル−3−(p
−)ルオイル)−ピロール−2−酢酸ナトリウムを40
01111のジメチルスルホキシド(DMSO)中に懸
濁した懸濁液に6.64P(0,088モル)のクロル
アセトニトリルを全部一度に加える。
Reference example 1 ■-Methyl-5- (p-)luoyl)-pyrrole-2
-1-methyl-3-(p
-) luoyl)-pyrrole-2-sodium acetate 40
To a suspension of 01111 in dimethyl sulfoxide (DMSO) is added 6.64 P (0,088 mol) of chloracetonitrile all at once.

混合物を室温で3.5時間攪拌する。The mixture is stirred at room temperature for 3.5 hours.

得られた淡黄色★溶液を焼結ガラス漏斗を通して瀝過す
る。
The resulting pale yellow solution is filtered through a sintered glass funnel.

p液を水中に注入して生成物1−メチル−5−(p −
トルオイル)−ピロール−2−酢酸シアンメチルを沈殿
させる。
The p solution was injected into water to produce the product 1-methyl-5-(p-
Toluoyl)-pyrrole-2-cyanmethyl acetate is precipitated.

沈殿を瀝過によって分離し、風乾し、アセトニトリルか
ら再結晶する。
The precipitate is separated by filtration, air-dried and recrystallized from acetonitrile.

融点131.5〜135℃。Melting point: 131.5-135°C.

参考例 2 参考例1の操作を繰返して式(IV)のシアンメチルエ
ステルを製造する。
Reference Example 2 The operation of Reference Example 1 is repeated to produce cyan methyl ester of formula (IV).

例えば実施例1の1−メチル−3−(p−トルオイル)
−ピロール−2−酢酸ナトリウムの代りに適当な式(I
I)のアルカリ金属塩の当量を用いることにより、それ
ぞれ次の生成物が得られる。
For example, 1-methyl-3-(p-toluoyl) in Example 1
-pyrrole-2-sodium acetate with a suitable formula (I
By using equivalents of the alkali metal salts of I), the following products are obtained in each case:

■−メチルー3−(p−)ルオイル)−ピロール−2−
酢酸2・2−ジメチル−1・3−ジオキソラニルメチル 15.81(0,0535モル)の1−メチル−5−(
p−)ルオイル)−ピロール−2−酢酸シアンメチルと
49.51(0,0376モル)のグリセリンのアセト
ンケタールと0.7462(0,0054モル)の炭酸
カリウムの溶液を90℃で2時間加熱する。
■-Methyl-3-(p-)luoyl)-pyrrole-2-
15.81 (0,0535 mol) of 1-methyl-5-(
A solution of p-)luoyl)-pyrrole-2-cyanomethyl acetate, 49.51 (0,0376 mol) of acetone ketal of glycerin, and 0.7462 (0,0054 mol) of potassium carbonate was heated at 90°C for 2 hours. do.

この混合物を冷却した後、水中に注入し、エーテルで抽
出する。
After the mixture has cooled, it is poured into water and extracted with ether.

有機相を塩什ナトリウムの飽和溶液で洗い、無水硫酸マ
グネシウム上で乾燥した後溶媒を蒸発させる。
The organic phase is washed with a saturated solution of sodium chloride, dried over anhydrous magnesium sulphate and the solvent is evaporated.

水蒸気浴温度で0.4miHgで蒸留することにより少
量のグリセリンのアセトンケタールを除去する。
A small amount of acetone ketal of glycerin is removed by distillation at 0.4 miHg at steam bath temperature.

メタノールで処理することにより、生成物1−メチル−
3−(p−トルオイル)−ピロール−2−酢酸2・2−
ヅメ1チルート3−ジオキソラニルメチルが結晶する。
By treatment with methanol, the product 1-methyl-
3-(p-Toluoyl)-pyrrole-2-acetic acid 2,2-
Zume 1 chiruto 3-dioxolanylmethyl crystallizes.

ヘキサンから再結晶後の融点は76.5−81℃である
The melting point after recrystallization from hexane is 76.5-81°C.

参考例 4 参考例3の操作に従って式(■)゛の2・2−ジメチル
−1・3−ジオキソラニルメチルエステルを製造するこ
とができる。
Reference Example 4 According to the procedure of Reference Example 3, 2,2-dimethyl-1,3-dioxolanyl methyl ester of formula (■) can be produced.

例えば参考例3で用いた1−メチル−3−(p −)ル
オイル)−ピロール−2−酢酸シアンメチルの代りに参
考例2で得た各シアンメチルエステルの当量を用いるこ
とにより、それぞれ対応する次の式の生成物を得ること
ができる。
For example, by using the equivalent amount of each cyan methyl ester obtained in Reference Example 2 in place of the 1-methyl-3-(p-luoyl)-pyrrole-2-acetate cyanmethyl used in Reference Example 3, the respective corresponding A product of the following formula can be obtained.

1−メチル−3−(p −トルオイル)−ピロール−2
−酢酸グリセリル 6.91(0,0186モル)の1−メチル−3=(p
−トルオイル)−ピロール−2−酢酸2・2−ジメチル
−1・3−ジオキソラニルメチルを45m1の氷酢酸お
よび187711の水に溶解した溶液を水蒸気浴上で3
0分間加熱する。
1-Methyl-3-(p-toluoyl)-pyrrole-2
-1-methyl-3=(p
A solution of 2,2-dimethyl-1,3-dioxolanylmethyl (-toluoyl)-pyrrole-2-acetate in 45 ml of glacial acetic acid and 187711 water was heated on a steam bath for 3 hours.
Heat for 0 minutes.

酢酸を蒸発させ、残留物をエーテルと水とに分配する。The acetic acid is evaporated and the residue is partitioned between ether and water.

エーテル相を分離し、製炭酸水素ナトリウム溶液および
塩化ナトリウム溶液で順次洗浄した後、無水硫酸マグネ
シウム上で乾燥する。
The ether phase is separated, washed successively with sodium bicarbonate solution and sodium chloride solution and then dried over anhydrous magnesium sulfate.

溶媒を蒸発させる。得られた生成物1−メチル−5−(
p −)ルオイル)−ピロール−2−酢酸グリセリルを
メタノールから1回、酢酸エチルとヘキサン(1:1)
の混合液から4回再結晶することによって精製する。
Evaporate the solvent. The resulting product 1-methyl-5-(
p-)luoyl)-pyrrole-2-glyceryl acetate from methanol once, ethyl acetate and hexane (1:1)
It is purified by recrystallization four times from a mixture of

融点92−95℃。Melting point 92-95°C.

Claims (1)

【特許請求の範囲】 1式 (ただし、Arはフェニルまたは低級アルキル置換フェ
ニルを表わし、Rは低級アルキルを表わす)によって表
わされる5−アロイル−ピロール酸のグリセリルエステ
ルの製造方法であって、式 (ただし、Xは上で定義した式(I)のカルボキシル官
能基に結合する残基部分である) の什合物を酢酸水溶液と加熱することを特徴とする製造
方法。
[Scope of Claims] A method for producing glyceryl ester of 5-aroyl-pyrolic acid represented by the formula 1 (wherein Ar represents phenyl or lower alkyl-substituted phenyl, and R represents lower alkyl), comprising: (wherein X is a residue moiety bonded to the carboxyl functional group of formula (I) defined above) A manufacturing method characterized by heating a mixture of the following with an aqueous acetic acid solution.
JP48009396A 1972-01-21 1973-01-22 Method for producing 5-aroyl-pyrrole glyceryl acetate Expired JPS5825671B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21986572A 1972-01-21 1972-01-21

Publications (2)

Publication Number Publication Date
JPS4880554A JPS4880554A (en) 1973-10-29
JPS5825671B2 true JPS5825671B2 (en) 1983-05-28

Family

ID=22821084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48009396A Expired JPS5825671B2 (en) 1972-01-21 1973-01-22 Method for producing 5-aroyl-pyrrole glyceryl acetate

Country Status (9)

Country Link
JP (1) JPS5825671B2 (en)
AT (1) AT323149B (en)
AU (1) AU476415B2 (en)
BE (1) BE794163A (en)
CA (1) CA1016949A (en)
CH (1) CH577965A5 (en)
DE (1) DE2302670A1 (en)
FR (1) FR2183661B1 (en)
GB (1) GB1385652A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62289493A (en) * 1986-06-09 1987-12-16 ヤマハ発動機株式会社 Mounting structure of starting motor for motorcycle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62289493A (en) * 1986-06-09 1987-12-16 ヤマハ発動機株式会社 Mounting structure of starting motor for motorcycle

Also Published As

Publication number Publication date
FR2183661B1 (en) 1975-11-21
FR2183661A1 (en) 1973-12-21
GB1385652A (en) 1975-02-26
AU476415B2 (en) 1976-09-23
CH577965A5 (en) 1976-07-30
JPS4880554A (en) 1973-10-29
AT323149B (en) 1975-06-25
AU5109473A (en) 1974-07-18
BE794163A (en) 1973-07-17
CA1016949A (en) 1977-09-06
DE2302670A1 (en) 1973-07-26

Similar Documents

Publication Publication Date Title
JPS582935B2 (en) 5↓-Production method of aroylpyrrole derivative
JPS5824585A (en) Novel theophylline derivative and manufacture
US2734904A (en) Xcxnhxc-nh
US4196292A (en) 6-Substituted amiloride derivatives
KR900004587B1 (en) Process for the preparation of phenylnaphthyridines
SU479290A3 (en) The method of obtaining 2- (furylmethyl) -6,7 benzomorfan
JPS5929050B2 (en) Production method of cyclohexanedione-(1,3)
JPS5845423B2 (en) Production method of new aminopropanol/derivatives
Cerecedo et al. Studies on thiazoles. I. 4-Methylthiazole-5-acetic acid and some of its derivatives
JPS5825671B2 (en) Method for producing 5-aroyl-pyrrole glyceryl acetate
JPS6019748B2 (en) Production method of isoindoline derivatives
US3086972A (en) Aza-thiaxanthene derivatives
US3007940A (en) Method of preparing derivatives of 3, 3-pentamethylene-4-hydroxybutyric acid
FR2460934A1 (en) ISOQUINOLINE DERIVATIVES CONTAINING SULFUR, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
GRUNDMANN et al. Triazines. XVII. s-Triazine from s-Triazine-2, 4, 6-tricarbonic Acid
JPH0352465B2 (en)
US3923996A (en) 3-Substituted-oxindoles in compositions and methods of treating obesity
US2839529A (en) Isothiazole compounds
KR880001715B1 (en) Process for preparing 1-furyl-3,4-dihydro-isoquinolines
SU438183A1 (en) The method of obtaining derivatives of eburnamine
US3860652A (en) 8-Aminoalkyl substituted dibenzobicyclo {8 3.2.1{9 {0 octadienes
US3119832A (en) Certain z-aryl-x-isoxazoline
US3244725A (en) 4, 5-diacyl-3-hydroxy-3-pyrrolin-2-ones
CA1076577A (en) Process for preparing hydrazinopyridazine derivatives
US3962284A (en) 3-(5-aryl-2-furyl)-3-hydroxypropionic acids and ethyl esters